A comprehensive study of cardiovascular risk factors, cardiac function and vascular disease in children with chronic

Choni Rinat1, Rachel Becker-Cohen, Amiram Nir

  • 1Pediatric Nephrology, Shaare Zedek Medical Center, Jerusalem, Israel. chrinat@szmc.org.il

Insights

Children with chronic kidney disease (CKD) show early signs of cardiovascular disease. Non-traditional risk factors like uric acid and homocysteine are key, highlighting the need for preventative strategies in this vulnerable pediatric population.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Research
  • Clinical Medicine

Background:

  • Cardiovascular disease (CVD) significantly impacts morbidity and mortality in pediatric chronic kidney disease (CKD).
  • CVD in CKD involves atherosclerosis, medial vascular calcifications, and myocardial disease.
  • Children with CKD offer a unique model to study kidney disease's role in CVD development, as atherosclerosis is less prevalent.

Purpose of the Study:

  • To investigate cardiovascular disease risk factors and manifestations in pediatric patients with chronic kidney disease stages 3-5.
  • To assess the relationship between CKD progression and both traditional and non-traditional cardiovascular risk factors.
  • To evaluate vascular and myocardial structure and function in relation to specific clinical and laboratory variables.

Main Methods:

  • Seventy patients (4 months to 18 years) with CKD stages 3-5 were evaluated.
  • Carotid artery ultrasound assessed vascular structure and function.
  • Echocardiography evaluated myocardial disease; laboratory tests assessed risk factors.

Main Results:

  • Traditional cardiovascular risk factors did not correlate with CKD progression.
  • Non-traditional risk factors, including elevated uric acid and homocysteine, increased with CKD stage.
  • Left ventricular hypertrophy and diastolic dysfunction were the primary myocardial abnormalities; vascular function correlated with calcium-phosphate metabolism.

Conclusions:

  • Pediatric CKD patients exhibit early cardiovascular disease risk factors and signs.
  • Uric acid and homocysteine may play significant roles in pediatric CKD-related cardiovascular disease.
  • Further research is needed to develop interventions preventing cardiovascular morbidity and mortality in this high-risk group.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...